Mirae Asset Global Investments
FULC icon

Mirae Asset Global Investments’s Fulcrum Therapeutics FULC Stock Holding History

Mirae Asset Global Investments’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Sell
2,980
-494
-14% -$3K ﹤0.01% 1564
2026
Q1 		$26.6K Buy
3,474
+844
+32% +$7.83K ﹤0.01% 1395
2025
Q4 		$29.7K Buy
+2,630
New +$26.8K ﹤0.01% 1488
2024
Q4 		– Sell
-2,257
Closed -$8.51K – 1624
2024
Q3 		$8.51K Buy
2,257
+401
+22% +$2.98K ﹤0.01% 1504
2024
Q2 		$11.7K Sell
1,856
-30,735
-94% -$233K ﹤0.01% 1449
2024
Q1 		$111K Buy
+32,591
New +$291K ﹤0.01% 2356
2023
Q2 		– Sell
-32,274
Closed -$92K – 2640
2023
Q1 		$92K Buy
32,274
+18,704
+138% +$168K ﹤0.01% 2460
2022
Q4 		$98.8K Buy
13,570
+18
+0.1% +$117 ﹤0.01% 2455
2022
Q3 		$110K Buy
+13,552
New +$97K ﹤0.01% 2480

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Mirae Asset Global Investments's FULC Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Fulcrum Therapeutics (FULC) stake by 14% in Q2 2026, selling an estimated $3K and leaving 2,980 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Mirae Asset Global Investments first reported a position in FULC in Q3 2022 and has held it in 9 quarters since. The position peaked at $111K in Q1 2024. 43 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Mirae Asset Global Investments held 2,980 shares of Fulcrum Therapeutics worth $10.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 494 Fulcrum Therapeutics shares in Q2 2026, an estimated $3K.
  • Fulcrum Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1564 holding.
  • Mirae Asset Global Investments first reported a position in Fulcrum Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Fulcrum Therapeutics position peaked at $111K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.